Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: December 19, 2019
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® in Patients With Atypical Hemolytic Uremic Syndrome
Search for trials
Clinical Trial
  • Status: Recruiting
  • Participants: 80
  • Start Date: December 9, 2019
US Post-Marketing Retrospective Observational Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)(TM)
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 75
  • Start Date: April 15, 2018
Usefulness of a Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in Pregnancy
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 31
  • Start Date: August 31, 2017
A Phase 3, Open-Label, Multicenter Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 58
  • Start Date: March 18, 2017
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical Trial
  • Status: Recruiting
  • Participants: 20000
  • Start Date: July 2010
Coordination of Rare Diseases at Sanford
Showing 1-10 of 10